Multiple Myeloma

Multiple Myeloma News

  • MGUS in 3% of Population: What to Do? Evidence for clinical practice and follow-up is limited, and experts offer suggestions based on the literature and their own practice at the Mayo Clinic.
  • What Is the Best-Selling Cancer Drug? While the immunotherapies are showing a staggering growth in sales, and biosimilars are already hurting sales, the top-selling cancer drug of last year may be a surprise.
 

Multiple Myeloma Perspective

  • Top News From ASH 2017: Slideshow Hot topics include moving to newer oral anticoagulants for cancer patients with VTE, plus practice-changing results in chronic lymphocytic leukemia, multiple myeloma, and Hodgkin's lymphoma.
  • Multiple Myeloma: Relapse Options Rewritten   In "Relapse Options Rewritten," Drs Joseph Mikhael and Keith Stewart provide an overview of the expanded array of new agents--several with overlapping indications--and offer guidance in the selection of therapies for patients with early relapsed disease.
 

Journals